Table of Contents Author Guidelines Submit a Manuscript
International Journal of Medicinal Chemistry
Volume 2014, Article ID 395637, 27 pages
http://dx.doi.org/10.1155/2014/395637
Review Article

Chemical Characteristics, Synthetic Methods, and Biological Potential of Quinazoline and Quinazolinone Derivatives

Department of Pharmacy, GRD (PG) Institute of Management and Technology, Dehradun, Uttarakhand 248009, India

Received 15 August 2014; Revised 11 September 2014; Accepted 16 September 2014; Published 13 November 2014

Academic Editor: Giulio Rastelli

Copyright © 2014 Mohammad Asif. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Connolly, D. Cusack, T. P. O’Sullivan, and P. J. Guiry, “Synthesis of quinazolinones and quinazolines,” Tetrahedron, vol. 61, no. 43, pp. 10153–10202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. Abida, P. Nayyar, and M. Arpanarana, “An updated review: newer quinazoline derivatives under clinical trial,” International Journal of Pharmaceutical & Biological Archive, vol. 2, no. 6, pp. 1651–1657, 2011. View at Google Scholar
  3. S. B. Mhaske and N. P. Argade, “The chemistry of recently isolated naturally occurring quinazolinone alkaloids,” Tetrahedron, vol. 62, no. 42, pp. 9787–9826, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. K. Mahato, B. Srivastava, and S. Nithya, “Chemistry structure activity relationship and biological activity of quinazoline-4(3H)-one derivatives,” Inventi Rapid: MedChem, vol. 2, no. 1, 2011. View at Google Scholar
  5. W. L. F. Armarego, A Text Book of Quinazolines, 1963.
  6. R. Rajput and A. P. Mishra, “A review on biological activity of quinazolinones,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 4, no. 2, pp. 66–70, 2012. View at Google Scholar · View at Scopus
  7. B. Pati and S. Banerjee, “Quinazolines: an illustrated review,” Journal of Advanced Pharmacy. Education & Research, vol. 3, no. 3, pp. 136–151, 2013. View at Google Scholar
  8. B. Vijayakumar, P. Prasanthi, K. M. Teja et al., “Quinazoline derivatives and pharmacological activities: a review,” International Journal of Medicinal Chemistry & Analysis, vol. 3, no. 1, pp. 10–21, 2013. View at Google Scholar
  9. X. Yang, H. Liu, H. Futa, R. Qiao, Y. Jiang, and Y. Zhao, “Efficient copper-catalyzed synthesis of 4-aminoquinazoline and 2,4-diaminoquinazoline derivatives,” Synlett, no. 1, pp. 101–106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. V. L. Truong and M. Morrow, “Mild and efficient ligand-free copper-catalyzed condensation for the synthesis of quinazolines,” Tetrahedron Letters, vol. 51, no. 4, pp. 758–760, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Shweta, S. Chirag, T. Bhawana, and J. Talesara, “Synthesis of phthalimido or succinimido[2-aryl-4-oxo-3-{2-phenyl-4(3H)- quinazolinon-3-yl}-1,3-thiazolidin-5-yl]ethanoate,” Journal of the Indian Chemical Society, vol. 86, no. 4, pp. 397–401, 2009. View at Google Scholar · View at Scopus
  12. O. O. Ajani, C. A. Obafemi, C. O. Ikpo, K. O. Ajanaku, K. O. Ogunniran, and O. O. James, “Comparative study of microwave assisted and conventional synthesis of novel 2-quinoxalinone-3- hydrazone derivatives and its spectroscopic properties,” International Journal of Physical Sciences, vol. 4, no. 4, pp. 156–164, 2009. View at Google Scholar · View at Scopus
  13. H. Mutlu and G. Irez, “Synthesis and characterization of new tridentate iminooxime ligands and their Co(III) complexes,” Turkish Journal of Chemistry, vol. 32, no. 6, pp. 731–741, 2008. View at Google Scholar · View at Scopus
  14. G. Abdel and H. A. W. Mohammed, “Design and synthesis of some new derivatives of 3H-quinazolin-4-one with promising anticonvulsant activity,” Acta Pharmaceutica, vol. 53, no. 2, pp. 127–138, 2003. View at Google Scholar · View at Scopus
  15. A.-F. E. Mourad, A. A. Aly, H. H. Farag, and E. A. Beshr, “Microwave assisted synthesis of triazoloquinazolinones and benzimidazoquinazolinones,” Beilstein Journal of Organic Chemistry, vol. 3, article 11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. N. M. Abdel Gawad, H. H. Georgey, R. M. Youssef, and N. A. El-Sayed, “Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6-disubstituted- 1, 2, 3, 4-tetrahydroquinazolin- 2H-ones,” European Journal of Medicinal Chemistry, vol. 45, no. 12, pp. 6058–6067, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. He, X. Wang, X. Zhao, Y. Liang, H. He, and L. Fu, “Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety,” European Journal of Medicinal Chemistry, vol. 54, pp. 925–930, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Marvania, P.-C. Lee, R. Chaniyara et al., “Design, synthesis and antitumor evaluation of phenyl N-mustard-quinazoline conjugates,” Bioorganic and Medicinal Chemistry, vol. 19, no. 6, pp. 1987–1998, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. H.-Q. Li, D.-D. Li, X. Lu, Y.-Y. Xu, and H.-L. Zhu, “Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activity,” Bioorganic and Medicinal Chemistry, vol. 20, no. 1, pp. 317–323, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Fernandes, C. Oliveira, L. Gano, A. Bourkoula, I. Pirmettis, and I. Santos, “Radioiodination of new EGFR inhibitors as potential SPECT agents for molecular imaging of breast cancer,” Bioorganic and Medicinal Chemistry, vol. 15, no. 12, pp. 3974–3980, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. K. G. Petrov, Y.-M. Zhang, M. Carter et al., “Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 17, pp. 4686–4691, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. A. S. Rosenthal, C. Tanega, M. Shen et al., “Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk),” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 10, pp. 3152–3158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Gellibert, M. H. Fouchet, V. L. Nguyen et al., “Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 8, pp. 2277–2281, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Wissner, H. L. Fraser, C. L. Ingalls et al., “Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2,” Bioorganic and Medicinal Chemistry, vol. 15, no. 11, pp. 3635–3648, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. M. N. Noolvi and H. M. Patel, “A comparative QSAR analysis and molecular docking studies of quinazoline derivatives as tyrosine kinase (EGFR) inhibitors: a rational approach to anticancer drug design,” Journal of Saudi Chemical Society, vol. 17, no. 4, pp. 361–379, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. A. Heath, M. M. Mehrotra, S. Chi et al., “Identification of 4-piperazin-1-yl-quinazoline template based aryl and benzyl thioureas as potent, selective, and orally bioavailable inhibitors of platelet-derived growth factor (PDGF) receptor,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 19, pp. 4867–4872, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Matsuno, T. Seishi, T. Nakajima et al., “Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation, part 4: structure-activity relationships for substituents on the quinazoline moiety of 4-[4-(N-substituted(thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives,” Bioorganic and Medicinal Chemistry Letters, vol. 13, no. 18, pp. 3001–3004, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. N. M. Heron, M. Anderson, D. P. Blowers et al., “SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 5, pp. 1320–1323, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. K. M. Foote, A. A. Mortlock, N. M. Heron et al., “Synthesis and SAR of 1-acetanilide-4-aminopyrazole-substituted quinazolines: Selective inhibitors of Aurora B kinase with potent anti-tumor activity,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 6, pp. 1904–1909, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. Chen, X. Huang, H. Yang et al., “Anti-tumor effects of B-2, a novel 2,3-disubstituted 8-arylamino-3H-imidazo[4,5-g]quinazoline derivative, on the human lung adenocarcinoma A549 cell line in vitro and in vivo,” Chemico-Biological Interactions, vol. 189, no. 1-2, pp. 90–99, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Ballard, R. H. Bradbury, C. S. Harris et al., “Inhibitors of epidermal growth factor receptor tyrosine kinase: Novel C-5 substituted anilinoquinazolines designed to target the ribose pocket,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 6, pp. 1633–1637, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. P. M. Chandrika, T. Yakaiah, A. R. R. Rao et al., “Synthesis of novel 4,6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines,” European Journal of Medicinal Chemistry, vol. 43, no. 4, pp. 846–852, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Zhu, J. Jin, C. Liu et al., “Synthesis and biological evaluation of novel quinazoline-derived human Pin1 inhibitors,” Bioorganic and Medicinal Chemistry, vol. 19, no. 9, pp. 2797–2807, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. A. S. El-Azab, M. A. Al-Omar, A. A. M. Abdel-Aziz et al., “Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: Molecular docking study,” European Journal of Medicinal Chemistry, vol. 45, no. 9, pp. 4188–4198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Cedric, T. Alexandra, T. Valerie et al., “Synthesis, biological evaluation and molecular modeling studies of quinazoline derivatives,” European Journal of Medicinal Chemistry, vol. 43, pp. 1469–1477, 2008. View at Google Scholar
  36. P. Selvam, P. Vijayalakshimi, D. F. Smee et al., “Novel 3-sulphonamido-quinazolin-4(3H)-one derivatives: Microwave-assisted synthesis and evaluation of antiviral activities against respiratory and biodefense viruses,” Antiviral Chemistry and Chemotherapy, vol. 18, no. 5, pp. 301–305, 2007. View at Google Scholar · View at Scopus
  37. G. D. Galarce, R. E. Foncea, A. M. Edwards, H. Pessoa-Mahana, C. D. Pessoa-Mahana, and R. A. Ebensperger, “Biological evaluation of novel 6-Arylbenzimidazo [1,2-c]quinazoline derivatives as inhibitors of LPS-induced TNF-alpha secretion,” Biological Research, vol. 41, no. 1, pp. 43–50, 2008. View at Google Scholar · View at Scopus
  38. K. S. Hatti, V. Chandregowda, G. Venkateswara Rao, A. Kush, and G. Chandrasekara Reddy, “In-silico interaction studies of quinazoline derivatives for their inhibitory action on both wild and mutant EGFRs,” Journal of Proteomics and Bioinformatics, vol. 2, no. 3, pp. 126–130, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Raffa, G. Daidone, B. Maggio, S. Cascioferro, F. Plescia, and D. Schillaci, “Synthesis and antileukemic activity of new 3-(5-methylisoxazol-3-yl) and 3-(pyrimidin-2-yl)-2-styrylquinazolin-4(3H)-ones,” Farmaco, vol. 59, no. 6, pp. 451–455, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. N. B. Patel and J. C. Patel, “Synthesis and antimicrobial activity of Schiff bases and 2-azetidinones derived from quinazolin-4(3H)-one,” Arabian Journal of Chemistry, vol. 4, no. 4, pp. 403–411, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Cakici, M. Catir, S. Karabuga et al., “Synthesis and biological evaluation of (S)-4-aminoquinazoline alcohols,” Tetrahedron Asymmetry, vol. 21, no. 16, pp. 2027–2031, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. P. M. S. Bedi, V. Kumar, and M. P. Mahajan, “Synthesis and biological activity of novel antibacterial quinazolines,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 20, pp. 5211–5213, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. A. M. Alafeefy, A. S. El-Azab, M. A. Mohamed, M. A. Bakhat, and S. G. Abdel-Hamid, “Synthesis of some new substituted iodoquinazoline derivatives and their antimicrobial screening,” Journal of Saudi Chemical Society, vol. 15, no. 4, pp. 319–325, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. V. Jatav, S. Kashaw, and P. Mishra, “Synthesis, antibacterial and antifungal activity of some novel 3-[5-(4-substituted phenyl) 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones,” Medicinal Chemistry Research, vol. 17, no. 2–7, pp. 169–181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Praveen Kumar, Y. Rajendra Prasad, N. R. Kumar, and S. Sridhar, “Synthesis and antimicrobial activity of 6,7,8,9-tetrahydro-5(H)-5- nitrophenylthiazolo[2,3-b]-quinazoline-3(2H)-one derivatives,” Asian Journal of Chemistry, vol. 20, no. 7, pp. 5161–5165, 2008. View at Google Scholar · View at Scopus
  46. K. Siddappa, T. Reddy, M. Mallikarjun, and C. V. Reddy, “Synthesis, characterization and antimicrobial studies of 3-[(2-hydroxy-quinolin-3-ylmethylene)-amino]-2-phenyl-3H-quinazolin-4-one and its metal(II) complexes,” E-Journal of Chemistry, vol. 5, no. 1, pp. 155–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. N. C. Desai, P. N. Shihora, and D. L. Moradia, “Synthesis and characterization of new quinazolines as potential antimicrobial agents,” Indian Journal of Chemistry, vol. 46, no. 3, pp. 550–553, 2007. View at Google Scholar · View at Scopus
  48. R. Suthakaran, S. Kavimani, P. Venkaiaiah, and K. Suganthi, “Synthesis and antimicrobial activity of 3-(2-(4z)-4-substituted benzylidene-4,5-dihydro-5-oxo-2-phenylimidazol-1-yl)ethyl)-6,8-un/dibromo subtituted-2-substituted quinazoline-(3H)-one,” Rasāyan Journal of Chemistry, vol. 1, no. 1, pp. 22–29, 2008. View at Google Scholar
  49. S. Jantová, Š. Stankovský, and K. Špirková, “In vitro antibacterial activity of ten series of substituted quinazolines,” Biologia, vol. 59, no. 6, pp. 741–752, 2004. View at Google Scholar · View at Scopus
  50. J. A. Patel, B. D. Mistry, and K. R. Desai, “Synthesis and antimicrobial activity of newer quinazolinones,” E-Journal of Chemistry, vol. 3, no. 2, pp. 97–102, 2006. View at Publisher · View at Google Scholar
  51. M. M. Ghorab, S. M. Abdel-Gawad, and M. S. A. El-Gaby, “Synthesis and evaluation of some new fluorinated hydroquinazoline derivatives as antifungal agents,” Farmaco, vol. 55, no. 4, pp. 249–255, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. G.-F. Xu, B.-A. Song, P. S. Bhadury et al., “Synthesis and antifungal activity of novel s-substituted 6-fluoro-4-alkyl(aryl)thioquinazoline derivatives,” Bioorganic and Medicinal Chemistry, vol. 15, no. 11, pp. 3768–3774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Omar and M. A. Ahmed, “Synthesis of some new 3H-quinazolin-4-one derivatives as potential Antitubercular agents,” World Applied Sciences Journal, vol. 5, no. 1, pp. 94–99, 2008. View at Google Scholar
  54. J. Í Kune, B. Jaroslav, M. Pour, K. Waisser, M. Iosárek, and J. Í Janota, “Quinazoline derivatives with antitubercular activity,” Farmaco, vol. 55, no. 11-12, pp. 725–729, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. V. K. Srivastava and A. Kumar, “Synthesis of newer thiadiazolyl and thiazolidinonyl quinazolin-4(3H)-ones as potential anticonvulsant agents,” European Journal of Medicinal Chemistry, vol. 37, no. 11, pp. 873–882, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Kumar, K. N. Dhawan, S. Vrat, K. P. Bhargava, and K. Kishore, “Synthesis of 6-substituted 2-phenyl-3-(5-substituted mercapto-1,3,4,thiadiazol-2-yl)quinazolin-4-(3H)-ones as antitubercular agents,” Archiv der Pharmazie, vol. 316, no. 9, pp. 759–763, 1983. View at Publisher · View at Google Scholar · View at Scopus
  57. K. S. Kumar, S. Ganguly, R. Veerasamy, and E. De Clercq, “Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones,” European Journal of Medicinal Chemistry, vol. 45, no. 11, pp. 5474–5479, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Schleiss, J. Eickhoff, S. Auerochs et al., “Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo,” Antiviral Research, vol. 79, no. 1, pp. 49–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. S. N. Pandeya, D. Sriram, G. Nath, and E. de Clercq, “Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methylmercapto quinazolin-4(3H)-one,” Pharmaceutica Acta Helvetiae, vol. 74, no. 1, pp. 11–17, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Kohli, S. R. Hashim, S. Vishal, M. Sharma, and A. K. Singh, “Synthesis and antibacterial activity of quinazolinone derivatives,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 1, no. 1, pp. 163–169, 2009. View at Google Scholar · View at Scopus
  61. C. Ye, J. You, X. F. Li et al., “Design, synthesis and anticoccidial activity of a series of 3-(2-(2-methoxyphenyl)-2-oxoethyl) quinazolinone derivatives,” Pesticide Biochemistry and Physiology, vol. 97, no. 3, pp. 194–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. J. You, C. Ye, Y. Weng, X. Mo, and Y. Wang, “Synthesis and anticoccidial activity of 4-(2-methoxyphenyl)-2- oxobutylquinazolinone derivatives,” Arkivoc, vol. 2008, no. 17, pp. 1–11, 2008. View at Google Scholar · View at Scopus
  63. A. M. Alafeefy, A. A. Kadi, O. A. Al-Deeb, K. E. H. El-Tahir, and N. A. Al-Jaber, “Synthesis, analgesic and anti-inflammatory evaluation of some novel quinazoline derivatives,” European Journal of Medicinal Chemistry, vol. 45, no. 11, pp. 4947–4952, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. R. S. Giri, H. M. Thaker, T. Giordano et al., “Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-κB and AP-1 mediated transcription activation and as potential anti-inflammatory agents,” European Journal of Medicinal Chemistry, vol. 44, no. 5, pp. 2184–2189, 2009. View at Publisher · View at Google Scholar
  65. V. Alagarsamy, V. Raja Solomon, and K. Dhanabal, “Synthesis and pharmacological evaluation of some 3-phenyl-2-substituted-3H-quinazolin-4-one as analgesic, anti-inflammatory agents,” Bioorganic and Medicinal Chemistry, vol. 15, no. 1, pp. 235–241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. K. Hemalatha and K. Girija, “Synthesis of some novel 2, 3-disubstituted quinazolinone derivatives as analgesic and anti-inflammatory agents,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 3, no. 2, pp. 103–106, 2011. View at Google Scholar · View at Scopus
  67. A. Kumar, S. Sharma, K. Bajaj et al., “Some new 2,3,6-trisubstituted quinazolinones as potent anti-inflammatory, analgesic and COX-II inhibitors,” Bioorganic and Medicinal Chemistry, vol. 11, no. 23, pp. 5293–5299, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. C. Balakumar, P. Lamba, D. Pran Kishore et al., “Synthesis, anti-inflammatory evaluation and docking studies of some new fluorinated fused quinazolines,” European Journal of Medicinal Chemistry, vol. 45, no. 11, pp. 4904–4913, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. S. M. Mosaad, K. I. Mohamed, M. A. Ahmed, G. A. Sami, and M. M. Adel, “Synthesis and anti-inflammatory evaluation of some quinazoline derivatives,” International Journal of Pharmacology, vol. 1, no. 3, pp. 261–266, 2005. View at Google Scholar
  70. C. H. Rajver, C. H. Swarnalatha, R. Stephen, and Sudharshini, “Synthesis of 6-bromo-oxo quinazoline derivatives and their pharmacological activities,” International Journal of Chemical Research, vol. 1, no. 1, pp. 21–24, 2010. View at Google Scholar
  71. M. Srivastav and S. M. Shantakumar, “Synthesis and Anti-inflammatory activity of some novel 3-(6-substituted-1,3-benzothiazole-2-yl)-2-[{(4-substituted phenyl) amino} methyl] quinazolines-4 (3H)-ones,” E-Journal of Chemistry, vol. 6, no. 4, pp. 1055–1062, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Omar, M. F. Fattah, M. M. Emad, M. I. Neama, and M. K. Mohsen, “Synthesis of some new quinazolin-4-one derivatives and evaluation of their antimicrobial and antiinflammatory effects,” Acta Poloniae Pharmaceutica: Drug Research, vol. 65, no. 1, pp. 11–20, 2008. View at Google Scholar · View at Scopus
  73. V. Jatav, P. Mishra, S. Kashaw, and J. P. Stables, “Synthesis and CNS depressant activity of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones,” European Journal of Medicinal Chemistry, vol. 43, no. 1, pp. 135–141, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. V. Jatav, P. Mishra, S. Kashaw, and J. P. Stables, “CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones,” European Journal of Medicinal Chemistry, vol. 43, no. 9, pp. 1945–1954, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. M. M. Aly, Y. A. Mohamed, K. A. M. El-Bayouki, W. M. Basyouni, and S. Y. Abbas, “Synthesis of some new 4(3H)-quinazolinone-2-carboxaldehyde thiosemicarbazones and their metal complexes and a study on their anticonvulsant,analgesic,cytotoxic and antimicrobial activities,” European Journal of Medicinal Chemistry, vol. 45, no. 8, pp. 3365–3373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. S. K. Kashaw, V. Kashaw, P. Mishra, N. K. Jain, and J. P. Stables, “Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl-4H-quinazolin-3-yl)-urea,” European Journal of Medicinal Chemistry, vol. 44, no. 11, pp. 4335–4343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. A. Gürsoy and N. Terzioğlu, “Synthesis and isolation of new regioisomeric 4-thiazolidinones and their anticonvulsant activity,” Turkish Journal of Chemistry, vol. 29, no. 3, pp. 247–254, 2005. View at Google Scholar · View at Scopus
  78. V. K. Pandey, S. Tusi, Z. Tusi et al., “Thiadiazolyl quinazolones as potential antiviral and antihypertensive agents,” Indian Journal of Chemistry Section B: Organic and Medicinal Chemistry, vol. 43, no. 1, pp. 180–183, 2004. View at Google Scholar · View at Scopus
  79. V. K. Srivastava and A. Kumar, “Synthesis of some newer derivatives of substituted quinazolinonyl-2-oxo/thiobarbituric acid as potent anticonvulsant agents,” Bioorganic and Medicinal Chemistry, vol. 12, no. 5, pp. 1257–1264, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Chioua, F. Benabdelouahab, M. Chioua, R. Martínez-Alvarez, and A. Herrera Fernández, “Synthesis of novel quinazoline derivatives via pyrimidine ortho-quinodimethane,” Molecules, vol. 7, no. 7, pp. 507–510, 2002. View at Publisher · View at Google Scholar · View at Scopus
  81. L. M. Werbel and M. J. Degnan, “Synthesis and antimalarial and antitumor effects of 2-amino-4-(hydrazino and hydroxyamino)-6-[(aryl)thio]quinazolines,” Journal of Medicinal Chemistry, vol. 30, no. 11, pp. 2151–2154, 1987. View at Publisher · View at Google Scholar · View at Scopus
  82. Y. Kabri, N. Azas, A. Dumètre et al., “Original quinazoline derivatives displaying antiplasmodial properties,” European Journal of Medicinal Chemistry, vol. 45, no. 2, pp. 616–622, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Madapa, Z. Tusi, A. Mishra et al., “Search for new pharmacophores for antimalarial activity. Part II. Synthesis and antimalarial activity of new 6-ureido-4-anilinoquinazolines,” Bioorganic and Medicinal Chemistry, vol. 17, no. 1, pp. 222–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. P. Verhaeghe, A. Dumtre, C. Castera-Ducros et al., “4-Thiophenoxy-2-trichloromethyquinazolines display in vitro selective antiplasmodial activity against the human malaria parasite Plasmodium falciparum,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 19, pp. 6003–6006, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. P. Verhaeghe, N. Azas, M. Gasquet et al., “Synthesis and antiplasmodial activity of new 4-aryl-2-trichloromethylquinazolines,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 1, pp. 396–401, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. T. P. Selvam, P. V. Kumar, and A. S. Kumar, “Synthesis and anti-oxidant activity of novel 6,7,8,9 tetra hydro- 5H-5-(2′-hydroxy phenyl)-2-(4′-substituted benzylidine)- 3-(4-nitrophenyl amino) thiazolo quinazoline derivatives,” Research in Biotechnology, vol. 1, no. 1, pp. 38–48, 2010. View at Google Scholar
  87. W. L. Armarego, The Chemistry of Heterocyclic Compound Fused Pyrimidines, vol. 11, part-1, 1967.
  88. K. C. Agarwal, V. Sharma, N. Shakya, and S. Gupta, “Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents,” Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 18, pp. 5474–5477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. Y. H. Kim, H. Choi, J. Lee et al., “Quinazolines as potent and highly selective PDE5 inhibitors as potential therapeutics for male erectile dysfunction,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 23, pp. 6279–6282, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Sasmal, D. Balasubrahmanyam, H. R. Kanna Reddy et al., “Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: part 2,” Bioorganic and Medicinal Chemistry Letters, vol. 22, no. 9, pp. 3163–3167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. V. Alagarsamy and U. S. Pathak, “Synthesis and antihypertensive activity of novel 3-benzyl-2-substituted-3H-[1,2,4]triazolo[5,1-b]quinazolin-9-ones,” Bioorganic and Medicinal Chemistry, vol. 15, no. 10, pp. 3457–3462, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. V. Alagarsamy, V. R. Solomon, and M. Murugan, “Synthesis and pharmacological investigation of novel 4-benzyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H1-antihistaminic agents,” Bioorganic and Medicinal Chemistry, vol. 15, no. 12, pp. 4009–4015, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. N. Schormann, S. E. Velu, S. Murugesan et al., “Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase,” Bioorganic and Medicinal Chemistry, vol. 18, no. 11, pp. 4056–4066, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. J. P. Patil, S. V. Amrutkar, and M. S. Ranawat, “Microwave assisted synthesis of quinazolinone using different bases,” Journal of Pharmaceutical Sciences and Research, vol. 1, no. 3, pp. 52–54, 2009. View at Google Scholar · View at Scopus
  95. E. Georgescu, F. Georgescu, M. R. Caira et al., “A new synthesis of pyrrolo[1,2-c]quinazoline from quinazolinium N-ylides: a re-investigation,” Arkivoc, vol. 2009, no. 12, pp. 232–241, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. Z. Rachid, M. MacPhee, C. Williams, M. Todorova, and B. J. Jean-Claude, “Design and synthesis of new stabilized combi-triazenes for targeting solid tumors expressing the epidermal growth factor receptor (EGFR) or its closest homologue HER2,” Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 18, pp. 5505–5509, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. S. H. Yang, D. B. Khadka, S. H. Cho et al., “Virtual screening and synthesis of quinazolines as novel JAK2 inhibitors,” Bioorganic and Medicinal Chemistry, vol. 19, no. 2, pp. 968–977, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. D. Kohli, S. R. Hashim, S. Vishal, M. Sharma, and A. K. Singh, “Synthesis and antibacterial activity of quinazolinone derivatives,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 1, pp. 163–169, 2009. View at Google Scholar · View at Scopus
  99. I. P. Jung, H. L. So, S. C. Chan, and S. K. Kwan, “Study on the selective reduction of 1H-quinazoline-2,4-diones,” Bulletin of the Korean Chemical Society, vol. 29, no. 6, pp. 1256–1258, 2008. View at Publisher · View at Google Scholar · View at Scopus